Evidence map›Paper›PMID 33121513›Full record

ArticleVirology journal2020

Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.

Jerome Rumdon Lon, Yunmeng Bai, Bingxu Zhong, Fuqiang Cai, Hongli Du

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Removal of SARS-CoV-2 viral markers through a water reclamation facility.Water environment research : a research publication of the Water Environment Federation · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research.International journal of peptide research and therapeutics · 2021
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jerome Rumdon LonSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, China.
Yunmeng BaiSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, China.
Bingxu ZhongSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, China.
Fuqiang CaiSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, China.
Hongli DuSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, China. hldu@scut.edu.cn.
South China University of Technology · CN

Funding

Key R&D Program of Guangdong Province 2019B020226001National Key R&D Program of China 2018YFC0910201the Science and the Technology Planning Project of Guangzhou 201704020176
6 · The paper itself

Abstract

backgroundIn order to obtain antibodies that recognize natural proteins, it is possible to predict the antigenic determinants of natural proteins, which are eventually embodied as polypeptides. The polypeptides can be coupled with corresponding vectors to stimulate the immune system to produce corresponding antibodies, which is also a simple and effective vaccine development method. The discovery of epitopes is helpful to the development of SARS-CoV-2 vaccine.

methodsThe analyses were related to epitopes on 3 proteins, including spike (S), envelope (E) and membrane (M) proteins, which are located on the lipid envelope of the SARS-CoV-2. Based on the NCBI Reference Sequence: NC_045512.2, the conformational and linear B cell epitopes of the surface protein were predicted separately by various prediction methods. Furthermore, the conservation of the epitopes, the adaptability and other evolutionary characteristics were also analyzed, the sequences of the whole genome of SARS-CoV-2 were obtained from the GISAID.

results7 epitopes were predicted, including 6 linear epitopes and 1 conformational epitope. One of the linear and one of the conformational consist of identical sequence, but represent different forms of epitopes. It is worth mentioning that all 6 identified epitopes were conserved in nearly 3500 SARS-CoV-2 genomes, showing that it is helpful to obtain stable and long-acting epitopes under the condition of high frequency of amino acid mutation, which deserved further study at the experiment level.

conclusionThe findings would facilitate the vaccine development, had the potential to be directly applied on the prevention in this disease, but also have the potential to prevent the possible threats caused by other types of coronavirus.

Indexed as

BetacoronavirusComputational BiologyCoronavirus Envelope ProteinsCoronavirus InfectionsCoronavirus M ProteinsCOVID-19COVID-19 VaccinesEpitopes, B-LymphocyteHumansImmunogenicity, VaccineModels, MolecularPandemicsPneumonia, ViralSARS-CoV-2Spike Glycoprotein, CoronavirusViral Envelope ProteinsCoronavirus Envelope ProteinsCoronavirus M ProteinsCOVID-19 Vaccinesenvelope protein, SARS-CoV-2Epitopes, B-Lymphocytemembrane protein, SARS-CoV-2Spike Glycoprotein, Coronavirusspike glycoprotein, SARS-CoVViral Envelope ProteinsViral Matrix ProteinsViral VaccinesBioinformaticsEpitopesEvolutionSARS-CoV-2

Identifiers

PMID33121513
PMCPMC7594941
OpenAlexW3095205894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.